Here is the latest stock price and chart of Divis Laboratories. For more details, see the Divis Laboratories company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since large caps interest you, here's our guide to buying bluechip stocks.
JUST IN: Limited-Time Access to Full Transcript of Our Urgent Broadcast on India's Revival
Live BSE Quotes | Apr 16, 2021 (Close) | ||
---|---|---|---|
Price (Rs)3,823.70 | Open (Rs) 3,808.00 | High (Rs) 3,844.00 | Low (Rs) 3,734.85 |
% Change1.08 | Volume 21,130 | Value (Rs) 80,027,233 | 52-Week H/L 3,913.00 / 2,094.60 |
Live NSE Quotes | Apr 16, 2021 (Close) | ||
---|---|---|---|
Price (Rs)3,821.85 | Open (Rs) 3,790.00 | High (Rs) 3,845.00 | Low (Rs) 3,733.40 |
% Change1.02 | Volume 681,099 | Value (Rs) 2,587,150,604 | 52-Week H/L 3,914.95 / 2,090.05 |
Change | |||||
---|---|---|---|---|---|
1 Day 1.08% | 1 Month 13.19% | 3 Months 7.27% | 1 Year 59.73% | 5 Years (CAGR)* 29.78% | 10 Years (CAGR)* 27.06% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 70.01 | P/E Ratio (x) 54.62 | Market Cap (Rs m) 1,015,069.99 | P/BV (x) 14.61 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
DIVIS LABORATORIES last traded price was up 1.1% to Rs 3,823.7 on the BSE. On the NSE, DIVIS LABORATORIES last traded price was up 1.0% to Rs 3,821.9. The total volume of shares traded was 0.7 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 1.9%. And the benchmark S&P BSE SENSEX was at 48,832.0 (up 0.1%).
Over the last 30 days, the DIVIS LABORATORIES share price is up 12.1%. And over the last one year, DIVIS LABORATORIES share price is up 59.8%.
What else is happening in the markets today? Dig in...
Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.
For the quarter ended December 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 27.9% YoY). Sales on the other hand came in at Rs 17 bn (up 19.1% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.
For the quarter ended June 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 84.1% YoY). Sales on the other hand came in at Rs 17 bn (up 50.0% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.
Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
This could take India to the position of 3rd largest economy.
In this video, I'll you what I think is the real reason behind yesterday's market crash.
This ignored sector could deliver big short-term profits.
More